ALTIUM CAPITAL MANAGEMENT LP – Neurocrine Biosciences, Inc. Transaction History
ALTIUM CAPITAL MANAGEMENT LP portfolio value:
$2.01M
portfolio value
ALTIUM CAPITAL MANAGEMENT LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.64% | -3K shares | -127K | $106.21 | 19K |
| Q2 2022 | share | Increase | 0.00% | 22K shares | 2.14M | $97.48 | 22K |